Search results
2 days ago · Get free historical data for ASTR. You'll find the closing price, open, high, low, change and %change of the AstraZeneca Pharma India Ltd. share for the selected range of dates. The data can be viewed in daily, weekly or monthly time intervals. At the bottom of the table you'll find the data summary for the selected range of dates. Time Frame.
Jun 25, 2024 · Positive high-level results from the NIAGARA Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival (EFS) and the key secondary endpoint of overall survival (OS) versus neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer (MIBC).
2 days ago · CHENNAI: AstraZeneca India, the global capability centre (GCC) of British- Swedish pharmaceutical company AstraZeneca, on Thursday announced expansion of its campus in Chennai with an investment ...
2 days ago · 11.16%. AZN. -0.25%. Chennai, July 4 (IANS) AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharma group AstraZeneca on Thursday said it will invest Rs 250 crore on expanding its Global Innovation and Technology Centre (GITC) here. The expansion includes close to 1,300 roles focused on driving innovation ...
1 day ago · AstraZeneca India Private Limited (AZIPL) has announced an INR 250 crore (USD 30 million) investment to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu.
4 days ago · AstraZeneca have also hugely contributed, shouldering much of the large-scale manufacturing burden. This isn’t something that any one lab, institution or sector can do alone. If we want to make an impact in bringing forward novel vaccines, we should fund large-scale facilities and consortia of researchers who all have their own role to play but work in collaboratively.
Jun 14, 2024 · Bangkok—AstraZeneca (Thailand) Ltd. has unveiled a significant three-year investment and partnership plan following a discussion with Thailand’s Prime Minister, Mr. Srettha Thavisin, on 12 June 2024 in Bangkok. The strategic partnership plan, in line with the government’s vision for Thailand to become a wellness and medical hub, underscores AstraZeneca's unwavering commitment to the well-being of the Thai community.
